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Substrate Rigidity Controls 
Activation and Durotaxis in 
Pancreatic Stellate Cells
Dariusz Lachowski  1, Ernesto Cortes1, Daniel Pink1, Antonios Chronopoulos1, Saadia A. 
Karim2, Jennifer P. Morton2 & Armando E. del Río Hernández1
Pancreatic Ductal Adenocarcinoma (PDAC) is an aggressive malignancy characterised by the presence 
of extensive desmoplasia, thought to be responsible for the poor response of patients to systemic 
therapies. Pancreatic stellate cells (PSCs) are key mediators in the production of this fibrotic stroma, 
upon activation transitioning to a myofibroblast-like, high matrix secreting phenotype. Given their 
importance in disease progression, characterisation of PSC activation has been extensive, however one 
aspect that has been overlooked is the mechano-sensing properties of the cell. Here, through the use 
of a physiomimetic system that recapitulates the mechanical microenvironment found within healthy 
and fibrotic pancreas, we demonstrate that matrix stiffness regulates activation and mechanotaxis 
in PSCs. We show the ability of PSCs to undergo phenotypic transition solely as a result of changes in 
extracellular matrix stiffness, whilst observing the ability of PSCs to durotactically respond to stiffness 
variations within their local environment. Our findings implicate the mechanical microenvironment 
as a potent contributor to PDAC progression and survival via induction of PSC activation and fibrosis, 
suggesting that direct mechanical reprogramming of PSCs may be a viable alternative in the treatment 
of this lethal disease.
Pancreatic Ductal Adenocarcinoma (PDAC) is a highly aggressive malignancy characterised by rapid progres-
sion, invasiveness and resistance to treatment1. The cancer is almost uniformly lethal with a dismal 5-year survival 
rate of less than 5%2 and a median survival time of 6 months from diagnosis3. Despite efforts over the past few 
decades, conventional treatment approaches such as chemotherapy, radiotherapy, and resection have had little 
impact on disease progression4, owing to the extreme resistance of pancreatic malignancies to all extant treat-
ments1. One of the unique and defining features of PDAC is the presence of remarkable stiffness and extensive 
desmoplasia surrounding the tumour5, which is thought to generate a unique microenvironment that facilitates 
cancer growth6, survival6–9 and metastasis10–12.
Through various in vivo and in vitro studies5, 10, 13–17 pancreatic stellate cells (PSCs) have been identified as the 
cell type responsible for the production and maintenance of this growth permissive microenvironment. Under 
normal conditions, these myofibroblast-like cells play a role in maintaining the normal tissue architecture of the 
pancreas14. Upon pancreatic injury, PSCs transition from a quiescent, vitamin A lipid storing phenotype18, to an 
activated state characterized by changes in migratory capacity and an increase in mitotic index and extracellular 
matrix secretion (ECM)19. In health, this ECM remodeling results in wound healing and the subsequent removal 
of activated PSCs through apoptosis20. In pancreatic cancer however, PSC activation is induced and maintained 
through the release of soluble growth factors and cytokines by cancer cells14, 21, resulting in the characteristic stro-
mal ‘reaction’ around the tumour. Once produced, this leads to a vicious cycle of accelerated cancer proliferation 
and subsequent mitogen production, perpetuating PSC activity6.
Given the role this desmoplastic stroma, and particularly PSCs, play in cancer progression and survival, 
research has accordingly switched to targeting aspects of the tumour microenvironment, such as PSCs and the 
pronounced fibrosis. Stromal ablation techniques however, have thus far been met with limited and somewhat 
contradictory results22, 23. Unlike stromal depletion strategies, stromal reprogramming is an emerging concept 
gaining acceptance as an attractive alternative PDAC therapy24. Such an approach is supported through a recent 
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report showing that vitamin D analogues are capable of transcriptionally reprogramming pancreatic stellate cells 
and overall tumour-associated stroma into a more quiescent state, which resulted in reduced tumour volume and 
an increase in intratumoral gemcitabine24.
It is well known that soluble profibrotic factors released from cancer cells activate both local14, 21 and distant25 
PSCs, which migrate from remote sites in the pancreas towards the tumour core. Here, crosstalk between acti-
vated PSCs and cancer cells promote PDAC carcinogenesis6 and chemoresistance6–9. Activated PSCs have also 
been shown to play a key role in cancer metastasis11, 12, participating in the formation of distant metastatic sites 
through co-migration with cancer cells11 and through the creation of ‘tracks’ within tissues, aiding in cancer cell 
migration26. Therefore, there is an urgent, currently unmet need in the field of pancreatic cancer to find therapies 
that induce PSC deactivation.
Interestingly, efforts thus far seem to overlook any potential role for the mechanical PDAC microenvironment 
in regulating PSC activity. The fact that PDAC is one of the most fibrotic and stroma-rich malignancies intui-
tively leads to the idea that extracellular matrix mechanics may play a key role in the development of fibrosis and 
PDAC progression. Studies that address the influence of mechanical force on PSC-PDAC interactions however, 
are severely lacking with some exceptions such as a recent study by Weaver and colleagues that has revealed that 
changes in matrix rigidity associated with PDAC fibrosis has a pronounced effect on the malignant epithelium, 
accelerating PDAC progression via changes in integrin-mediated mechanosignalling. This leads to the notion 
that ECM rigidity may also alter the ECM tensional homeostasis to influence the activity of PSCs in the stromal 
compartment of the tumour, therefore accelerating the development of fibrosis within a positive feedback loop27.
In a first attempt to mechanically reprogram PDAC-associated stroma, our group reported that ATRA, an 
active metabolite of vitamin A, restores mechanical quiescence in PSCs, in an actomyosin dependent manner and 
inhibiting local cancer cell invasion in 3D organotypic models28. Such studies, however, involve analysis of cells 
cultured on glass – a substrate with rigidity in the order of GPa29 – and as such fail to recapitulate a biologically 
relevant environment. It is a well-known phenomenon that transdifferentiation of PSCs to an active phenotype 
occurs during culture on glass30, however the question of whether or not PSCs possess the ability to mechani-
cally sense the rigidity of their local fibrotic environment and undergo phenotypic transition solely as a result of 
mechanical stress has never been addressed. Furthermore, whilst the ability of PSCs to chemotactically migrate 
towards pancreatic neoplasms has been well defined25, whether or not PSCs display durotactic behaviours within 
this microenvironment has not been explored.
Here, through the use of a physiomimetic system that recapitulates the mechanical microenvironment found 
within healthy and fibrotic pancreas, we show that matrices mirroring rigidities found within fibrotic pan-
creas activate PSCs, whilst matrices resembling healthy pancreas induce and maintain quiescence in previously 
activated PSCs. Moreover, activated PSCs were also observed to undergo durotactic migration towards stiffer, 
fibrotic-like regions; a response previously characterized in fibroblasts31, but not reported before in PSCs.
Results
Matrigel induces PSC quiescence. Transition of quiescent PSCs to an activated myofibroblast-like state is 
a well-documented phenomenon that occurs upon cell culture30. Indeed, all fibroblasts grown in standard culture 
conditions are myofibroblast by definition, given that contact with the stiff surface of culture flasks triggers the 
formation of contractile stress fibres32. As a result, the assessment of any potential mechano-sensory regulation of 
PSC activity is not possible using this setup. To address this issue, we sought to implement an in vitro model that 
allows us to culture PSCs in a quiescent state. Transdifferentiated culture-activated PSCs were grown on a layer of 
Matrigel for 6 days to induce cell quiescence, following an in vitro method identified by Jesnowski et al.30. Matrigel 
culture resulted in reversion of activated PSCs to a quiescent-like state. Cells lost their spindle morphology and 
Oil Red staining was used to confirm the presence of cytoplasmic lipid droplets characteristic of PSC quiescence 
(Fig. 1a).
Our observations are in agreement with previous results described by Jesnowski et al.30, and confirm that 
Matrigel culture of activated PSCs results in the reversion of cells to a resting-like state. In addition to resump-
tion of lipid storing ability, cells on Matrigel began to form cell clusters connected by a filamentous network 
(Supplementary Fig. S1), further mirroring earlier observations by Jesnowski et al.30. Taken together, these results 
indicate the ability of Matrigel to revert culture-activated PSCs to a state of quiescence, whilst indicating the 
matrix surrounding PSCs plays a pivotal role in the maintenance of PSC activation30.
Production of a physiomimetic model recapitulating soft and stiff substrates. The ability of cells 
to sense and respond to environmental mechanical force is a key determinant in tissue homeostasis33. Whilst 
activation of PSCs in physiological conditions is a well-regulated defined process, the unabated activation leads 
to sustained fibrosis34. Although prior observations are suggestive, there has of yet been no direct demonstration 
that PSCs are able to adapt behaviour based on the mechanical properties of their substrate. To explore if the 
exogenous mechanical environment is enough in itself to regulate PSC activity, a physiomimetic model represent-
ing soft and stiff tissues was produced.
Polyacrylamide (PAA) gels of varying rigidity – 1 kPa (soft matrix) or 25 kPa (stiff matrix) – were prepared 
according to Engler’s protocol35, through alteration of gel acrylamide/bis-acrylamide ratios (Supplementary 
Table S1). Cell culture on these synthetic hydrogels requires the coupling of a cell-adhesive matrix protein in 
order to provide proper cell attachment to the gel surface35. Through the use of the substrate-protein crosslinker 
sulpho-SANPAH36, gels were crosslinked with the ECM protein fibronectin (Supplementary Fig. S2), yielding a 
mechanically tunable, chemically identical PAA hydrogel system, capable of providing a platform upon which to 
investigate how substrate stiffness regulates PSC behaviour.
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Stiff matrices induce PSC activation. PDAC is intrinsically one of the most fibrotic and rigid human 
malignancies, ascribed in part, to the dense collagenous stroma that surrounds the neoplasm10. To identify if this 
stiff mechanical microenvironment is enough alone to induce PSC activation, Matrigel-induced quiescent PSCs 
were seeded onto PAA hydrogels resembling soft (1 kPa) and stiff (25 kPa) tissues, referred hereafter as soft and 
stiff, respectively. After 24 hours of culture, we used Oil Red staining to identify the presence of any cytoplas-
mic lipid droplets characteristic of PSC quiescence (Fig. 1a). We observed that quiescent PSCs seeded onto soft 
matrices retained the ability to store lipid droplets, suggesting maintenance of a resting-like state. Quantification 
of seeded cell populations revealed a statistically significant difference (p < 0.001) in total Oil Red staining levels 
between PSCs on soft (95% stained) and those on stiff (20%) hydrogels (Fig. 1b). To further validate our observa-
tions, we tested the expression of alpha smooth muscle actin (αSMA) and vimentin, two widely used markers for 
quiescence in PSCs, at the gene and protein levels10, 37. We observed no significance difference in the mRNA levels 
of αSMA and vimentin of PSCs seeded on Matrigel (standard technique to induce PSCs quiescence) and soft 
matrices. Conversely, we found a two-fold increase in the mRNA levels of αSMA and vimentin of PSCs seeded on 
stiff matrices compared to soft matrices and Matrigel (Fig. 1c,d). At the protein level, we observed a similar trend, 
no significant differences in the expression of αSMA and vimentin between PSCs on matrigel and soft matrix, 
Figure 1. Stiff matrices induce PSC activation. (a) Bright-field images of Oil Red O stained PSCs on Matrigel, 
soft and stiff matrices for 6 days. Scale bar 25 μm. (b) Quantification of Oil Red O staining after 24-hour culture 
on soft or stiff PAA matrices showed a significant reduction in staining levels on stiff matrix when compared 
to soft matrix, indicating cellular activation almost entirely on stiff matrix rigidities. (c,d) pPCR mRNA levels 
of αSMA and vimentin for conditions represented in (a). (e,f) Quantification of staining intensity for αSMA 
and vimentin for conditions represented in (a), images in Supplementary Fig. 3. In all cases, histogram bars 
represent mean ± SEM. Representative of 3 independent experiments with more than 20 cells analysed in 
(b,e,f), ***p < 0.001, **p < 0.01.
www.nature.com/scientificreports/
4Scientific RepoRts | 7: 2506  | DOI:10.1038/s41598-017-02689-x
and a significant increase in both proteins expressions when PSCs were on stiff matrices (Figs 1e,f and S3). We 
also observed that stiff substrates increase PSC proliferation and fibronectin expression (Supplementary Fig. S4).
Taken together that quiescent PSCs seeded onto stiffer matrices were observed to lose lipid-storing capacity, 
express the canonical markers characteristic of PSC activation, and increase proliferation & ECM protein pro-
duction, these observations indicate that substrate stiffness can, per se, induce phenotypic transition of PSCs to a 
matrix-secreting active state. Serum conditions were kept the same throughout the experiments, indicating that 
the observed changes occurred irrespective of the presence of any soluble factors.
Soft matrices induce and maintain PSC quiescence. Many conditions featuring pathological tissue 
fibrosis occur as a result of sustained myofibroblast activity18. This persistent activation is a consequence of the 
establishment of a mechanical feedback loop, which perpetuates myofibroblast matrix secretion through the sens-
ing and promotion of a stiff microenvironment28. Restoring ECM mechanics to normalcy or the ability of the 
cell to perceive the elevated ECM rigidity is sufficient to terminate the feedback loop and abrogate myofibroblast 
activity, cells typically undergoing de-differentiation to a quiescent state32. To investigate whether PSCs exhibit 
this mechano-induced state ‘fluidity’, previously glass culture-activated PSCs were transferred and grown on soft 
or stiff PAA hydrogels for 3 days, with Oil Red staining employed to identify cell phenotypic state. Cells cul-
tured on stiff matrices were shown to remain continually active, with PSCs lacking lipid-storing ability (Fig. 2a). 
Conversely, PSCs grown on soft matrices began to regain cytoplasmic lipid droplets (Fig. 2a), indicative of a 
resumption of quiescence.
Quantification of these populations (Fig. 2b) revealed, as expected, the complete absence of any Oil Red stain-
ing on stiff matrices (0% stained), indicating a population-wide maintenance of PSC activation. On soft hydrogels 
however, after 3 days of culture 22% of the previously outright culture-active population had reverted to a state 
of quiescence; nearly a quarter of cells regaining lipid-storing capacity (Fig. 2b). Given these findings, we next 
tested whether further prolonged growth on soft matrices would increase population phenotypic transition to 
a quiescent state. Glass culture-activated PSCs were grown on soft matrices for a total of 9 days, with Oil Red 
staining of samples occurring in 3-day intervals to assess PSC population quiescence (Fig. 2c). Staining levels at 3 
days (21% stained) were in agreement with our earlier observations, with 6 days (26%) and 9 days (46%) yielding 
a significant increase in population quiescence.
To learn more about the effect of matrix rigidity on PSCs activation, we next investigated the expression of 
αSMA and vimentin at the gene and protein levels, as markers of PSCs activation. Consistent with our previous 
observation, the αSMA and vimentin mRNA levels in PSCs seeded onto stiff matrices were not statistically dif-
ferent from those plated on glass; while the expressions of these two markers on PSCs seeded onto soft matrices 
were markedly suppressed with regard to glass and stiff matrix (50% and 40% reduction for αSMA and vimentin, 
respectively) indicating the induction of quiescence on PSCs seeded on soft matrices (Fig. 2d,e). We observed 
the same trend at the protein level for both markers (Figs 2f,g and S5). Furthermore, we also observed that soft 
substrates induce a decrease in PSC proliferation and fibronectin expression (Supplementary Fig. S6).
In order to explore the physiological relevance of our findings, we investigated the activation levels of PSCs in 
normal (Pdx1-Cre) and fibrotic pancreas associated to PDAC (Pdx-1 Cre, LSL-KrasG12D/+, LSL-Trp53R172H/+) in 
mice models. Using immunofluorescence to detect αSMA, and second harmonic generation (SHG) to visualize 
collagen-I, we observed abundant expression and co-localization of αSMA and collagen-I in PDAC fibrotic tis-
sues. This indicates the presence of active PSCs (αSMA expression used as a surrogate of PSC activation) secret-
ing high levels of ECM proteins. In stark contrast with this, we only observed αSMA expression and collagen 
deposition in ductal areas of normal pancreas tissues (Fig. 3).
Thus, taken collectively, our data indicate that PSCs are capable of returning to a resting state within a 
mechanically relevant model of pancreatic fibrosis. Furthermore, these observations directly highlight the impor-
tance of the mechanical microenvironment in regulating PSC behaviour, with our results identifying that the stiff 
microenvironment found within PDAC plays a pivotal role in maintaining the matrix secreting PSC phenotype.
PSCs exhibit directed migration across a stiffness gradient. Durotaxis, the ability of cells to detect 
and move along gradients in substrate stiffness31, has been well characterized in fibroblasts38. Such migration 
provides a novel mechanism through which gradients of matrix stiffness can facilitate and drive the progression 
of fibrosis39. Given the differences in matrix rigidity between the fibrotic PDAC microenvironment and normal 
pancreas, we set out to identify if PSCs possess any durotactic behaviour. We produced a double-rigidity PAA 
hydrogel system through juxtaposition of functionalized soft and stiff matrices, resembling a model originally 
used to observe durotactic migration in fibroblasts38. Regions of different rigidities were outlined through embed-
ding of fluorescent beads within the stiff region of substrate (Fig. 4a). Culture-active PSCs were seeded onto this 
dual-rigidity hydrogel and after 30 minutes (to allow attachment), observations were made through time-lapse 
phase contrast microscopy every 15 minutes over a period of 12 hours. Observations took place simultaneously 
within the soft, stiff and boundary regions of the hydrogel.
Cell movement distance within each region was calculated by subtraction of initial (0 hours) from final 
(12 hours) cell position coordinates along the ‘x’ axis, with migration only analysed when movement along the 
‘y’ axis, perpendicular to the gradient axis, was 0. This allows for exclusion of factors other than rigidity gradient 
in affecting cell movement. Positive ‘x’ values indicate a preference of PSCs to migrate towards regions of fibro-
sis, whilst negative ‘x’ values indicate migration in the opposite direction. Values close to 0 highlight random, 
undirected cell movement. We observed the preferential ability of PSCs to durotactically migrate from soft to 
stiff matrices (Fig. 4b and Supplementary Video S1), with quantification of average ‘x’ values outlining a marked 
predilection of PSCs to migrate from soft to stiff within the boundary region of hydrogels (Fig. 4c). Cells observed 
within single rigidity regions of the gel (solely soft or stiff), as expected, exhibited random movement along the ‘x’ 
axis, with PSCs present within these regions displaying no directed motility (Fig. 4c).
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PSC movement speed was also assessed as a function of migration, determined in relation to cell movement 
distance over the experiment duration (12 hours). As to be expected, cells undergoing directed migration within 
the boundary region exhibited significantly increased migratory speed in comparison to cells residing within 
single rigidity regions (Fig. 4d).
Figure 2. Soft matrices induce PSC deactivation. (a) Bright-field images of Oil Red O stained PSCs on glass, 
soft and stiff matrices for 6 days. Scale bar 25 μm. (b) Cell population Oil Red staining levels after 3 days on soft 
or stiff PAA matrices show that active PSCs on soft matrix begin to revert back to quiescence. Representative 
of 3 independent experiments with 33 cells analysed. (c) Cell population Oil Red O staining levels after 3, 6 
and 9 days on soft matrix confirm that culture of active PSCs on soft matrices reverts cells back into a resting 
state in a time-dependent manner. (d,e) pPCR mRNA levels of aSMA and vimentin for conditions represented 
in (a). (f,g) Quantification of staining intensity for αSMA and vimentin for conditions represented in (a), 
images in Supplementary Fig. 5. In all cases, histogram bars represent mean ± SEM. Data are representative of 3 
independent experiments and 221 cells analysed in (c), *p < 0.05, **p < 0.01, ***p < 0.001, n.s. non-significant.
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Figure 3. αSMA is highly expressed and co-localises with collagen-I in PDAC tissues but αSMA expression 
is markedly decreased in normal pancreatic tissues from mice. Immunofluorescence images combined with 
second harmonic generation (SHG) signal of normal and PDAC tissues from mice. Scale bar 100 μm. Collagen I 
SHG shown in red.
Figure 4. Durotactic response of PSCs. (a) Fluorescent image of rigidity boundary between soft (1 kPa) and 
stiff (25 kPa) PAA matrices. Yellow-green FluoSpheres were embedded into stiff hydrogels. (b) Representative 
example of PSC migration from soft to stiff regions over a 5-hour period. Scale bar 25 μm. Over time the 
cell (highlighted with a white arrow) moved towards the left (stiffer substrate). (c) Average cell migration 
distance observed at the rigidity boundary, soft region and stiff region of the hydrogel over a 12-hour period. 
Positive values indicate movement towards higher rigidity, values close to 0 indicate random, undirected 
movement. PSCs exposed to a stiffness gradient expressed a marked predilection towards stiff substrate, with 
those exposed to only a single rigidity exhibiting undirected, limited movement. Number of cells analysed per 
region: boundary – 51; soft – 67; stiff – 78. *p < 0.05. (d) Average cell movement speed observed at the rigidity 
boundary, soft region and stiff region of the hydrogel over a 12-hour period. PSCs exposed to a stiffness gradient 
exhibit markedly increased migratory speed when compared to PSCs exposed to only a single rigidity. Number 
of cells analysed per region: boundary – 51; soft – 67; stiff – 78. *p < 0.05, In all cases, histogram bars represent 
mean ± SEM. Data are representative of 3 independent experiments.
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Cell migration and hence durotaxis depend on very tightly coordinated processes of focal adhesion turnover 
and detachment of the adherent rear edge via myosin-II mediated contractile forces. Interfering with normal 
spatiotemporal focal adhesion dynamics or cell contractility impairs durotaxis in fibroblasts and mesenchymal 
stem cells40, 41. To learn more about the mechanisms underlying durotaxis in PSCs, we used siRNA against focal 
adhesion kinase (siRNA FAK), and blebbistatin that inhibits myosin-II ATPase activity and cell contractility. As 
expected, down regulating FAK or cell contractility profoundly decreased durotaxis in PSCs, evidenced by close 
to null average of PSCs movement in the x-axis, which is indicative of random non-directed movement (Fig. 5a,b 
and Supplementary Videos S2 and S3).
Taken together, our data show that PSCs possess the ability to durotactically migrate towards regions of fibro-
sis within a mechanically relevant model of PDAC. We demonstrate that such motility occurs in the absence of 
any chemotactic stimuli, highlighting another avenue through which PSCs contribute to the production of des-
moplasia around pancreatic neoplasms, whilst providing a potential additional mechanism through which PSCs 
play a role in cancer metastasis.
Discussion
PDAC is a highly aggressive malignancy characterised by persistent activation of pancreatic stellate cells (PSCs), 
resulting in excessive ECM deposition and secretion of soluble factors, which provides both mechanical and bio-
chemical cues that in turn influence all aspects of tumour progression. Furthermore, the tumour-associated fibro-
sis in PDAC not only impedes intratumoural drug perfusion, but also alters the mechanical microenvironment 
by increasing matrix stiffness. This can in turn alter force transmission and deregulate the tensional homeostasis 
of resident PSCs leading to a perpetual cycle of fibrosis and aberrant PSC activation.
Figure 5. FAK and myosin-II activities are required for durotaxis in PSCs. (a) Average cell migration 
distance at the rigidity boundary over a 12-hour period for control PSCs, PSCs transfected with siRNA for 
FAK, and PSCs treated with blebbistatin. Positive values indicate movement towards higher rigidity, values 
close to 0 indicate random, undirected movement. Histogram bars represent mean ± SEM. ***p < 0.001. (b) 
Representative images of PSC migration over a 5 h period. Scale bar 25 μm.
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Given that activated PSCs are the main effector cells in pancreatic fibrosis, targeting PSCs can offer a novel 
therapeutic approach to normalise the tumour stroma. In the past, research has primarily focused on identifying 
soluble profibrogenic and pro-migratory factors – cytokines and growth factors that mediate PSC activation and 
migration, with most notable examples, transforming growth factor (TGF-β1) and platelet-derived growth factor 
(PDGF). Matrix stiffness has traditionally been thought of as a manifestation of disease rather than a contributor 
to fibrosis and as a result little attention was paid so far to the mechanical microenvironment as a stimulus for 
PSC activation and migration.
It has previously been shown that activated PSCs possess the ability to mechanically activate latent TGF-β 
stored within the ECM42, producing an autocrine feedback loop that independently sustains PSC fibrotic 
activity42. Furthermore, we have previously shown, using a 3-dimensional model of ECM, that activated PSCs 
apply higher tension on collagen fibres, producing a greater degree of collagen alignment and fibre thickness43  
that ultimately perpetuates fibrosis and creates the collagen fibre tracks that are used by cancer cells to 
migrate26. Abrogating PSC activation through tuning matrix rigidity, cytoskeletal contractility, or normalising 
integrin-mediated mechanosensing thus holds the potential to both suppress mechanical activation of latent 
TGF-β, and change the alignment of ECM architecture that is conducive to cancer cell invasion and survival44.
Here, we show a newly identified PSC mechano-sensory regulation within an in vitro physiomimetic model 
of PDAC. Stiff PAA hydrogels, mimicking the PDAC mechanical microenvironment, were shown to induce PSC 
phenotypic transition to an activated, higher matrix secreting state. This force-mediated activation could explain 
the perpetuation of established fibrosis. Once resident PSCs are activated through soluble factors released by can-
cer cells, the matrix secreted by these PSCs creates higher tissue tension in the local microenvironment around 
the tumour. This increase in stiffness leads to the generation of a positive mechanical feedback loop that both 
induces and maintains PSC activation (Fig. 6) in the stroma, irrespective of the presence of any soluble factors.
Contrarily, soft matrices, recapitulating healthy pancreas modulus, were demonstrated to induce and maintain 
PSC quiescence, disproving the idea that apoptosis is solely responsible for termination of PSC activation45. The 
feasibility of stellate cell inactivation is also consistent with previous reports that suggest hepatic stellate cells can 
revert back to a quiescent state upon resolution of liver fibrosis, although still retaining an intermediate pheno-
type with enhanced capacity to respond to fibrogenic signals46. Such observations may also shed light as to why 
current therapies targeting the depletion of the myofibroblastic stroma have thus far yielded limited results22, 23.
Furthermore, we identified a previously unobserved durotactic response within PSCs, cells preferentially 
migrating towards regions of fibrosis on a mechanically relevant dual-rigidity PAA hydrogel. Thus, it can be 
expected that within the PDAC pancreas, such durotactic behaviours complement the already characterised PSC 
chemotactic movement25 in being responsible for the observed increase in activated PSC numbers around the 
neoplasm47. This increase leads to further matrix deposition and subsequent growth of desmoplasia that, in turn, 
increases durotactic capacity of yet more PSCs, leading to the generation of a positive durotactic feedback loop 
that complements the aforementioned mechanical loop (Fig. 6).
Figure 6. Illustration of PSC mechano-sensory driven regulation within a PDAC microenvironment. Under 
the effects of activating factors released from nearby cancer cells, local PSCs undergo phenotypic transition to a 
myofibroblast-like state, characterised by the secretion of vast amounts of ECM, providing a growth permissive 
environment for the neoplasm. Independently of PSC-cancer cell interactions, the generation of this highly 
stiff matrix mechanically activates local PSCs through mechanotransduction of the local microenvironment. 
This leads to increased matrix secretion and further PSC mechano-activation, resulting in the production of a 
positive mechanical activation feedback loop that produces a continually expanding region of fibrosis around 
the tumour. Such deposition leads to the generation of a stiffness gradient within the pancreas that is sensed by 
distant quiescent PSCs, causing them to undergo transition to an active state and begin durotactic migration 
towards the neoplasm, where upon they contribute to further matrix deposition. This accentuates the ever-
growing area of fibrosis around the neoplasm through a vicious cycle of mechanically perturbed PSC activity.
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Taken together, our findings suggest that matrix stiffness can induce myofibroblastic differentiation of PSCs, 
independently of soluble profibrotic factors (e.g. TGF-β), as well as promote durotactic migration to stiffer fibrotic 
regions independently of chemotactic stimuli, (e.g. PDGF). Targeting matrix stiffness and mechanotransduction 
could open new avenues for treatment of pancreatic fibrosis (PDAC and chronic pancreatitis) and fibroprolif-
erative diseases in general. One such avenue includes the recent demonstration that aside from matrix rigidity, 
cells also sense the length of adhesive ligands that attach them to the matrix48. Such information opens up the 
possibility for engineering applications that make use of longer ‘relaxed’ artificial adhesive tethers that allow PSCs 
to perceive stiff environments as soft, abrogating fibrotic behaviour.
An alternative and currently more tangible option28, 42 is targeted deactivation of PSCs removing the growth 
permissive microenvironment which surrounds the tumour. Furthermore, through targeting of the mechano-
sensing properties of PSCs, such treatments have the potential to abrogate PSC mechanical activation of TGF-β42, 
inhibit PSC durotactic migration towards the tumour core and suppress the ability of PSCs to create ‘tracks’ 
within tissues for further cancer cell invasion26. Inhibition of this migratory capacity not only inhibits the cross-
talk between PSCs and cancer cells, but also may play an important role in preventing the formation of metastatic 
niches28.
Materials and Methods
Cell culture and reagents. Human primary PSCs were purchased from ScienCell Research Laboratories 
(Carlsbad, USA) and cultured in DMEM/F-12 HAM (Sigma-Aldrich, USA) supplemented with 10% FBS (Gibco, 
USA), 1% penicillin/streptomycin (Sigma-Aldrich, USA) and 1% Fungizone (Gibco, USA). Cells were tested for 
contamination and cultured until passage 4–8 was reached.
Quiescence induction using Matrigel assay. PSC quiescence was induced through culture of cells on 
Matrigel for 6 days. Corning Matrigel Basement Membrane Matrix, LDEV-free (Scientific Laboratory Supplies, 
UK) was prepared on ice in a 1:2 ratio with serum-free DMEM/F-12 HAM. Homogenised solution was used to 
coat sterile positively charged microscope slides/13 mm sterile glass coverslips and left to polymerise for 24 hours 
at 37 °C. PSCs were then seeded on top of Matrigel and cultured at 37 °C, 5% CO2 with media changed every 2–3 
days.
Preparation of polyacrylamide hydrogels of tunable stiffness. Single rigidity PAA hydrogels were 
prepared through homogenisation of a polymer solution containing: PBS, acrylamide/bisacrylamide (29:1) 
40% volume (Sigma-Aldrich, USA), TEMED (Sigma-Aldrich, USA) and 10% APS. Varying hydrogel rigidi-
ties were produced through alteration of acrylamide/bisacrylamide amounts (Supplementary Table S1) based 
on Engler’s protocol35. 8 μl (gel attachment to coverslips)/100 μl (microscope slide) drop(s) of desired polymer 
solution were then transferred to dichlorodimethylsilane (Sigma-Aldrich, USA) treated glass microscope slides 
before ‘activated’ 13 mm glass coverslips/‘activated’ glass microscope slide treated with: 0.1 M NaOH, 4% APTES 
(Sigma-Aldrich, USA) and 2.5% glutaraldehyde (Sigma-Aldrich, USA), were placed on top. Gels were incubated 
for 45–60 minutes to allow polymerisation before gentle removal from the dichlorodimethylsilane treated micro-
scope slide using a sterile scalpel. Gels were then sterilized under 2 × 30 minutes of UV light and where necessary 
submerged in PBS and stored at 4 °C.
To produce double rigidity PAA hydrogels suitable for durotaxis analysis, 2.5 μl yellow-green 0.2 μm 
FluoSpheres carboxylate (Molecular Probes, USA) were added to one of two hydrogel polymer solutions so as 
to distinguish the boundary between rigidities. FluoSpheres were activated by sonication for 7 seconds. Two 4 μl 
droplets (one containing FluoSpheres) of varying hydrogel stiffness were placed adjacent to each other on an 
‘activated’ glass dish. A dichlorodimethysilane treated coverslip was placed on top and gels allowed to polymerise 
for 45–60 minutes before gentle removal of coverslip.
To facilitate cell attachment to gels, 50 μl (coverslip)/200 μl (microscope slide) sulfo-SANPAH (SS) 
(Sigma-Aldrich, USA) solution (0.1 mg SS in 2 μl DMSO/50 μl PBS) was used to covalently bind native human 
fibronectin (Gibco, USA) to gel surface. Gel surface was covered in SS solution and exposed to 2 × 5 minutes UV 
light to activate sulfo-SANPAH before excess solution was removed through PBS washing. 50 μl (coverslip)/200 μl 
(microscope slide) of fibronectin solution (10 μl fibronectin/1 ml PBS) was added to gel surface and gels incubated 
at RT for 2 hours. Excess fibronectin was then removed with gentle PBS washing. Cells were then added and 
cultured.
Oil Red O staining. Oil Red O stock solution was prepared with 60 mg Oil Red O powder (Sigma-Aldrich, 
USA) dissolved in 20 ml 100% isopropanol and stored at RT in dark. Working solution was prepared by adding 3 
parts stock to 2 parts dH20, left to sit for 10 minutes, and then filtered through a 0.2 μm syringe filter. Cells were 
fixed with 1% PFA, washed with PBS, then incubated with 60% isopropanol for 5 minutes at RT. Isopropanol 
was removed and cells submerged in Oil Red O working solution for 20 minutes on a dish rocker. Samples were 
washed with distilled water until clear and stored in distilled water at 4 °C.
Immunofluorescence. Cells were fixed with 4% PFA, blocked and permeabilised with 2% BSA and 0.1% 
Triton X-100 (all Sigma-Aldrich, St. Louis, MO, USA) then incubated with primary antibodies (Vimentin M0725 
DAKO, Alpha SMA M0851 DAKO, Ki67 ab15580 abcam, Fibronectin ab2413 abcam) 1/100 diluted in 2% 
BSA/PBS for 1 hour at RT, then washed with PBS and incubated with secondary antibodies (Alexa Fluor® 488 
anti-rabbit Life Technologies, USA) and phalloidin (Alexa Fluor® 546, A22283, Life Technologies, USA) 1/500 
in PBS for 45 min in dark. Finally the coverslips were mounted with ProLong® Gold Antifade with DAPI (Life 
Technologies, USA).
www.nature.com/scientificreports/
1 0Scientific RepoRts | 7: 2506  | DOI:10.1038/s41598-017-02689-x
Image acquisition and quantitative analysis. Oil Red O images were taken with a Motic AE31 trinoc-
ular inverted microscope by Motic Images Plus 2.0 software using 20x objective. Oil Red O staining was analysed 
on Matrigel/PAA hydrogels through bright-field microscopy based on the presence/absence of red-stained lipid 
droplets within cell cytoplasm. Quantification of cell population quiescence per condition was assessed as the 
number of cells stained positively for Oil Red O within that condition. Immunofluorescent images were taken 
with Nikon Ti-e inverted microscope by NIS elements software using 40x objective. Immunofluorescent staining 
was analysed on Matrigel/PAA hydrogels through epifluorescence microscopy based on the mean fluorescence 
intensity. The immunofluorescent images of pancreas OCT frozen sections and collagen second harmonic gener-
ation images were taken with Leica SP5 MP/FLIM upright multiphoton microscope.
Quantification and analysis of durotaxis on polyacrylamide hydrogels. Durotactic responses of 
cells were analysed with a Nikon Ti-Eclipse microscope using 20x objective. After cell seeding (control, with 
50 µM blebbistatin and with siRNA FAK sc-29310 Santa Cruz Biotechnology transfected with Neon Transfection 
System, ThermoFisher) onto double rigidity hydrogels, samples were transferred to microscope culture cham-
ber (37 °C, 5% CO2) and gently submerged in 5 ml of growth media. Rigidity boundary was identified through 
yellow-green fluorescence of FluoSpheres. ‘Regions of interest’ (ROI) across the sample were stitched together 
using NIS elements software to generate a representative image of the hydrogel surface. x- and y-axis were used to 
define these ROI within the ‘soft’, ‘stiff ’, and ‘soft-stiff boundary’ regions of the hydrogel, whilst the z-axis was used 
to focus the camera onto the surface plane of the gel. A period of 1–2 hours was set to allow cells to fully attach to 
gel surface before time-lapse phase contrast images were taken every 15 minutes for 12 hours within each desig-
nated ROI. Coordinates and distances of cell movement were calculated using the Fiji “Manual Tracking” plugin.
Real-time quantitative polymerase chain reaction. Total RNA was extracted with RNeasy Mini Kit 
(Qiagen, 74104) and 1 µg of total RNA was reverse transcribed by High-Capacity RNA-to-cDNA Kit (Applied 
Biosystems, 4387406) according to manufacturer’s instructions. Q-PCR was performed with SYBR Green 
PCR Master Mix (Applied Biosystems, 4309155) with 100 ng cDNA input in 20 µl reaction volume. GAPDH 
expression level was used for normalisation as a housekeeping gene. The sequences were as following: GAPDH: 
forward-5′ACAGTTGCCATGTAGACC3′, reverse-5′TTTTTGGTTGAGCACAGG3′; a-SMA: forward-5′CAT-
CATGAAGTGTGACATCG3′, reverse-5′GATCTTGATCTTCATGGTGC3′; vimentin: forward-5′G-
GAAACTAATCTGGATTCACTC3′, reverse-5′CATCTCTAGTTTCAACCGTC3′. All primers were used at 
300 nM final concentration. The relative gene expression was analysed by comparative 2−ΔΔCt method.
Mouse Tissues. Mouse tissues for healthy pancreas (Pdx-1-Cre) and PDAC (Pdx1-Cre; LSL-KrasG12D/+ 
LSL-Trp53R127H/+) were obtained from Dr. Jennifer Morton at the Beatson Institute in Glasgow. All experimental 
protocols were conducted in compliance with the UK Home Office guidelines under license and approved by the 
local ethical review committee (Beatson Cancer Research UK Institute, Glasgow).
Multiphoton Microscopy. All SHG images were obtained using a custom built multiphoton microscope 
incorporating an upright confocal microscope (SP5, Leica) and a mode-locked Ti:Sapphire Laser (Mai Tai, 
Newport Spectra-Physics). Images of the SHG signal from collagen I were collected using an 820 nm excitation 
with SHG signal obtained with a 414/46 nm bandpass filter and multiphoton autofluorescence signal obtained 
with a 525/40 nm bandpass filter. A 25X, 0.95 NA water-immersion objective (Leica) was used to deliver the 
excitation signal and to collect the SHG emission signal from the sample.
Statistical analysis. Results were analysed using Prism software. A two-tailed Student’s t-test for unpaired 
data or ANOVA plus Tukey posthoc test was used to calculate the difference between means, with p-values less 
than 0.05 considered significant. Single asterisk show *p < 0.05, double asterisk show **p < 0.01, triple asterisk 
show ***p < 0.001. Data is presented as means, with error bars the standard error of the mean (SEM).
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